Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vagisan vaginal suppository in postmenopausal women with vulvovaginal atrophy
2019-002325-30Phase 2Completed
- Sponsor
- Dr. August Wolff
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lactic acid in vaginal atrophy, sponsored by Dr. August Wolff. Primary endpoint: Change in Vaginal Maturation Index. Started Jun 2019; status: completed.
02
Drugs
lactic acid
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2019-002325-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002325-30.